SIRION Biotech to present Viral Vector Know-How Hub to support Cell & Gene Therapy R&D at ESGCT 2022

SIRION Biotech GmbH News Releases

Find the latest News from SIRION Biotech GmbH

Home / News Releases

SIRION Biotech to present Viral Vector Know-How Hub to support Cell & Gene Therapy R&D at ESGCT 2022

SIRION Biotech to present Viral Vector Know-How Hub to support Cell & Gene Therapy R&D at ESGCT 2022

Thursday 6th October 2022

By SIRION Biotech… Learn More >

SIRION Biotech to present insights on single cell level gene delivery to ASGCT 25th Anniversary Meeting

SIRION Biotech to present insights on single cell level gene delivery to ASGCT 25th Anniversary Meeting

Friday 6th May 2022

By SIRION Biotech… Learn More >

SIRION Biotech achieves ISO-9001:2015 Certification

SIRION Biotech achieves ISO-9001:2015 Certification

Wednesday 6th April 2022

By SIRION Biotech… Learn More >

SIRION teams with Centre for Genomic Regulation to develop NextGen AAV vectors for diabetes gene therapies

SIRION teams with Centre for Genomic Regulation to develop NextGen AAV vectors for diabetes gene therapies

Tuesday 15th March 2022

By SIRION Biotech… Learn More >

PerkinElmer agrees to acquire SIRION Biotech

PerkinElmer agrees to acquire SIRION Biotech

Friday 30th July 2021

By SIRION Biotech… Learn More >

SIRION Biotech scoops double GHP Biotechnology Awards for 2021

SIRION Biotech scoops double GHP Biotechnology Awards for 2021

Friday 28th May 2021

By SIRION Biotech… Learn More >

SIRION Biotech to collaborate with Sanofi on improved AAV capsids

SIRION Biotech to collaborate with Sanofi on improved AAV capsids

Thursday 11th March 2021

By SIRION Biotech… Learn More >

Mustang Bio Provides Updates on its Lentiviral Gene Therapies for the Treatment of X-linked Severe Combined Immunodeficiency (“XSCID”)

Mustang Bio Provides Updates on its Lentiviral Gene Therapies for the Treatment of X-linked Severe Combined Immunodeficiency (“XSCID”)

Friday 12th February 2021

By SIRION Biotech… Learn More >

SIRION Biotech GmbH licensed its LentiBOOST™ transduction technology to Cellectis

SIRION Biotech GmbH licensed its LentiBOOST™ transduction technology to Cellectis

Wednesday 3rd February 2021

By SIRION Biotech… Learn More >

SIRION brings viral vector expertise to BioFIT 2020 virtual event

SIRION brings viral vector expertise to BioFIT 2020 virtual event

Wednesday 2nd December 2020

By SIRION Biotech… Learn More >

SIRION Biotech licenses LentiBOOST™ Technology to Mustang Bio for development of XSCID gene therapy

SIRION Biotech licenses LentiBOOST™ Technology to Mustang Bio for development of XSCID gene therapy

Wednesday 4th November 2020

By SIRION Biotech… Learn More >

Bavaria supports SIRION in development of AAV-delivered protective antibodies against coronaviruses

Bavaria supports SIRION in development of AAV-delivered protective antibodies against coronaviruses

Thursday 1st October 2020

By SIRION Biotech… Learn More >